CFSAN program priorities
This article was originally published in The Rose Sheet
Executive Summary
FDA is requesting comments on FY 2005 program priorities for the Center for Food Safety & Applied Nutrition, agency announces in a June 24 Federal Register 1notice. CFSAN anticipates "there will be considerable continuity between the 2004 and 2005 workplans," the notice states. FY 2004 "A" list priorities include a review of phthalates and completion of a labeling guidance on alpha hydroxy acid-containing products (2"The Rose Sheet" May 10, 2004, p. 5). Workplan also will follow the format of the FY 2004 plan, which was divided into four sections - assessing food safety and security, improving nutrition and dietary supplement safety, assuring food and cosmetic safety and assuring food safety: cross cutting areas. Comments are due Aug. 9, and the program priorities will be released this fall, the notice states. FDA's fiscal year begins Oct. 1...
You may also be interested in...
Phthalate Cosmetics Survey Placed On CFSAN Priority List
Amid growing controversy over the use of phthalates in cosmetics, FDA's Center for Food Safety & Applied Nutrition announced that a review of the chemicals is one of the Office of Cosmetics & Colors "A" list priorities for fiscal 2004 (ending Sept. 30)
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.